Hans-Peter Gerber
Chief Tech/Sci/R&D Officer at SUTRO BIOPHARMA, INC.
Net worth: - $ as of 2024-04-29
Hans-Peter Gerber active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-09-17 | - |
| T-CURX GmbH | Chairman | - | - |
Career history of Hans-Peter Gerber
Former positions of Hans-Peter Gerber
| Companies | Position | Start | End |
|---|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Director/Board Member | 2016-12-31 | 2020-12-31 |
| Independent Dir/Board Member | 2016-12-31 | 2020-12-31 | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Director/Board Member | 2015-12-31 | 2017-12-31 |
| President | 2015-12-31 | 2017-12-31 |
Training of Hans-Peter Gerber
| University of Zurich | Doctorate Degree |
Statistics
International
| United States | 3 |
| Switzerland | 3 |
| Germany | 2 |
Operational
| Director/Board Member | 2 |
| President | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
| T-CURX GmbH |
- Stock Market
- Insiders
- Hans-Peter Gerber
- Experience
